Recombinant PTK2B anticorps

N° du produit ABIN7515921

L’anticorps anti-PTK2B Monoclonal Lapin est utilisé pour la détection de PTK2B dans des échantillons de Humain. Il a été validé pour WB, IHC (p) et IP.

Aperçu rapide pour Recombinant PTK2B anticorps (ABIN7515921)

Antigène: PTK2B (PTK2B Protein tyrosine Kinase 2 beta (PTK2B))

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Lapin

Clonalité: Monoclonal

Conjugué: Cet anticorp PTK2B est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunoprecipitation (IP)

Clone: R03-8D2

Détail du produit anti-PTK2B anticorps

Fonction: Rabbit recombinant monoclonal antibody raised against human PTK2B.

Réactivité croisée: Humain

Immunogène: Original antibody is raised against recombinant protein corresponding to human PTK2B.

Isotype: IgG

Information d'application

Indications d'application: Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections),Immunoprecipitation,Western Blot,The optimal working dilution should be determined by the end user.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: In 50 mM Tris-Glycine, pH 7.4, (0.15M NaCl, 40 % Glycerol, 0.01 % Sodium azide and 0.05 % BSA)

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Store at 4°C. For longer storage, aliquot and store at -20°C.
Aliquot to avoid repeated freezing and thawing.

Détails sur PTK2B

Antigène: PTK2B (PTK2B Protein tyrosine Kinase 2 beta (PTK2B))

Autre désignation: PTK2B

Sujet: PTK2B protein tyrosine kinase 2 beta

ID gène: 2185

Pathways: EGFR Signaling Pathway, Regulation of Actin Filament Polymerization, Carbohydrate Homeostasis, Glycosaminoglycan Metabolic Process, Cellular Glucan Metabolic Process, Cell-Cell Junction Organization, Regulation of Cell Size, Regulation of Carbohydrate Metabolic Process, Hepatitis C, Protein targeting to Nucleus, CXCR4-mediated Signaling Events, Signaling Events mediated by VEGFR1 and VEGFR2, Signaling of Hepatocyte Growth Factor Receptor, Positive Regulation of fat Cell Differentiation, VEGF Signaling